Related Experiment Videos
Second-line drugs for arthritis: the reasons for early use
1Dundee Teaching Hospitals NHS Trust.
The Practitioner
|June 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis.
Rheumatology (Oxford, England)·2008
Bone health in patients with fibromyalgia.
Rheumatology (Oxford, England)·2003
Rheumatoid arthritis and macrovascular disease.
Rheumatology (Oxford, England)·2003
A non-infective cause of recurrent purulent arthritis.
Scandinavian journal of rheumatology·2002
Improving pain control in diabetic neuropathy.
The Practitioner·2017
Tailor management to the patient with fibroids.
The Practitioner·2017
Preventing stroke and assessing risk in women.
The Practitioner·2017
Early referral improves long-term outcomes in rheumatoid arthritis.
The Practitioner·2017
Diagnosing and managing mild cognitive impairment.
The Practitioner·2017
Be vigilant for dementia in Parkinson’s disease.
The Practitioner·2017
Lycopene Attenuates DEHP-Induced Cerebral Injury by Suppressing cGAS-STING-Mediated Microglial Activation.
Journal of agricultural and food chemistry·2026
Synergistic Combination of Cryptolepis sanguinolenta (Lindl.) Schlechter (Apocynaceae) and Azadirachta Indica (A. Juss) (Meliaceae) Against 3D7 and DD2 Strains of Plasmodium Falciparum.
Advances in pharmacological and pharmaceutical sciences·2026
Cordycepin ameliorates ischemia/reperfusion-induced acute kidney injury via inhibiting apoptosis and necroptosis.
Iranian journal of basic medical sciences·2026
Potential Iatrogenic Harms From Medicinal Cannabis Prescribing in Australia: A Case Series.
Drug and alcohol review·2026